Day: November 17, 2020

NoHo Partners Oyj: Johdon liiketoimet (Niemi)

Written by Customer Service on November 17, 2020. Posted in Public Companies.

NoHo Partners OyjJOHDON LIIKETOIMET 17.11.2020 klo 17.35NoHo Partners Oyj: Johdon liiketoimet (Niemi)Yllä ilmoitetut luovutukset ovat yhteensä 23 797 osaketta.Lisätietoja:Jarno Vilponen, talousjohtaja, NoHo Partners Oyj, puh. +358 40 721 9376Jakelu:Nasdaq HelsinkiKeskeiset tiedotusvälineetwww.noho.fiNoHo Partners Oyj on vuonna 1996 perustettu suomalainen ravintola-alan palveluihin erikoistunut konserni. Vuonna 2013 ensimmäisenä suomalaisena ravintolatoimijana NASDAQ Helsinkiin listautunut pörssiyhtiö on kasvanut voimakkaasti koko historiansa ajan. Konsernin yhtiöihin kuuluu noin 250 ravintolaa Suomessa, Tanskassa ja Norjassa. Yhtiön tunnettuja ravintolakonsepteja ovat mm. Elite, Savoy, Teatteri, Yes Yes Yes, Stefan’s Steakhouse, Palace, Löyly, Hanko Sushi, Friends & Brgrs ja Cock’s & Cows. NoHo Partners Oyj:n vuoden 2019...

Pennexx Releases its Quarterly Report Showing Revenue and Talks About the Potential Value of Users

Written by Customer Service on November 17, 2020. Posted in Public Companies.

Philadelphia, PA, Nov. 17, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Pennexx has conducted an analysis that shows the potential value of gaining its first million user goal on Your Social Offers ( https://yoursocialoffers.com ).Using figures by Forbes (https://www.forbes.com/sites/tristanlouis/2013/08/31/how-much-is-a-user-worth/?sh=4c7ab3181c51 ), a million consumer users could be estimated to value a company at $120 Million dollars. In that article Forbes found the average user to be worth $120.84, and the average revenue per user to be $3.76. Pennexx estimates that this is an appropriate value for users that join YSO as a consumer. However, we believe YSO’s merchant users are much more valuable on an individual basis. YSO has begun its subscription service at $25 per month and believes that by offering merchants more than...

Athenex 宣佈將在 2020 年聖安東尼奧乳癌研討會 (SABCS) 介紹口服紫杉醇及 Encequidar 的數據

Written by Customer Service on November 17, 2020. Posted in Public Companies.

口服紫杉醇用於轉移性乳癌的關鍵第 3 期臨床試驗的無惡化存活期及整體存活期更新數據焦點海報紐約州水牛城, Nov. 17, 2020 (GLOBE NEWSWIRE) — Athenex, Inc. (NASDAQ: ATNX) 是一家國際生物製藥公司，致力研究、開發及將用於治療癌症和相關疾病的新療法商業化，該公司今天宣佈於將於 12 月 8 日至 11 日舉行的 2020 年聖安東尼奧乳癌研討會 (SABCS)，以四張單獨海報介紹口服紫杉醇及 encequidar（「口服紫杉醇」）數據。簡報將包括口服紫杉醇用於轉移性乳癌的關鍵第 3 期臨床試驗的無惡化存活期 (PFS) 及整體存活期 (OS) 的焦點海報，以及神經病變 (CIPN) 及管理腸胃副作用的海報。另一張海報探討口服紫杉醇用於治療乳房皮膚血管瘤。研討會還設有 CIPN、醫療事務及齊來面對轉移性乳癌計劃等獨特中心，帶來沉浸式 Athenex Oncology 虛擬展覽體驗。口服紫杉醇簡報的詳情如下：焦點海報簡報摘要標題：口服紫杉醇及 Encequidar (oPac+E) 與靜脈注射紫杉醇 (IVPac) 用於治療轉移性乳癌患者（研究：KX-ORAX-001）會議：焦點海報討論 1計劃編號：PD1-08日期及時間：2020 年 12 月 9 日（星期三）下午 4:00 至 5:15 中部時間 (CT)如欲了解更多資訊，請瀏覽：https://www.sabcs.org/Program/Spotlight-Sessions/Spotlight-Poster-Discussion-1選定用於焦點海報的摘要只會在 SABCS 網站上發佈標題，直至 2020 年 12 月 9 日禁止發佈解除為止，屆時，將會在網上發佈完整的摘要。其他海報簡報摘要標題：口服紫杉醇及 Encequidar (oPac+E) 用於治療皮膚血管瘤：乳房血管瘤組計劃編號：PS13-05會議：海報會議 13日期及時間：2020 年...

Update: Global WholeHealth Partners, Corp (GWHP: OTC) Describes the Pros and Cons of the Common Types of COVID-19 Test Kits Available

Written by Customer Service on November 17, 2020. Posted in Public Companies.

San Clemente, CA, Nov. 17, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — The coronavirus disease 2019 (COVID-19) pandemic has placed the world in a tailspin, which the healthcare industry has responded to in kind with the development and rapid deployment of tests designed to detect infection. Many of these tests help clinicians and researchers accurately identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19.And while these tests have been crucial in identifying and tracking cases of infection and disease-related morbidity and mortality, they aren’t without their potential drawbacks.Types of COVID-19 TestsSeveral new methods have been developed to diagnose COVID-19, many of which have their own alternative methods of administration and unique benefits:Antigen Rapid, point-of-care...

Willis Towers Watson launches Tech, Media and Telecom Differentiated Broking Solutions

Written by Customer Service on November 17, 2020. Posted in Public Companies.

ARLINGTON, Va., Nov. 17, 2020 (GLOBE NEWSWIRE) — Willis Towers Watson (NASDAQ: WLTW), a leading global advisory, broking and solutions company, today announced the launch of its Tech, Media and Telecom Differentiated Broking Solutions (TMT DBS). This solution adds to the roster of existing DBS programs of General Industry DBS, Financial Institutions DBS and Real Estate DBS.The TMT DBS will serve clients in several industries, including electronics, hardware, semiconductor, internet, data networking, telecom, print media, broadcast and advertising, and software and tech services. The TMT DBS builds on the current Willis Towers Watson TMT Panel for small enterprises and will provide coverage for clients with $50 million to $5 billon in turnover.Coverage for TMT DBS is available for the property & casualty sector and includes...

Park Aerospace Corp. Announces Celebration of 60th Anniversary of its Initial Public Offering

Written by Customer Service on November 17, 2020. Posted in Public Companies.

NEWTON, Kan., Nov. 17, 2020 (GLOBE NEWSWIRE) — Park Aerospace Corp. announced the celebration of the 60th anniversary of its initial public offering, which occurred on November 17, 1960. Park’s IPO was for 175,000 shares of Common Stock, $.10 par value per share, at a price of $4.00 per share, or a total value of $700,000. Park’s Common Stock was originally listed on the American Stock Exchange under the ticker symbol PKE, and the listing was transferred to the New York Stock Exchange on April 25, 1984, where Park’s Common Stock continues to trade to this day under the PKE symbol. (The Company was originally listed under the name “Park Electrochemical Corp.” The Company changed its name to Park Aerospace Corp. on July 17, 2019.)Brian Shore, Park’s Chairman and CEO, said, “To me, our 60 years as a public company have been wonderful...

Once-weekly semaglutide 2.0 mg demonstrates superior reduction in HbA1c vs once-weekly semaglutide 1.0 mg in people with type 2 diabetes in the SUSTAIN FORTE trial

Written by Customer Service on November 17, 2020. Posted in Public Companies.

Bagsværd, Denmark, 17 November 2020 – Novo Nordisk today announced headline results from the SUSTAIN FORTE trial, a phase 3b 40-week, efficacy and safety trial with once-weekly semaglutide 2.0 mg vs once-weekly semaglutide 1.0 mg as add-on to metformin and/or sulfonylureas in 961 people with type 2 diabetes in need for treatment intensification. The trial achieved its primary endpoint by demonstrating a statistically significant and superior reduction in HbA1c at week 40 with semaglutide 2.0 mg compared to semaglutide 1.0 mg.When evaluating the effects of treatment taken as intended1 and from a high mean baseline HbA1c of 8.9%, people treated with semaglutide 2.0 mg achieved a statistically significant and superior reduction in HbA1c of 2.2% compared with a reduction of 1.9% with semaglutide 1.0 mg at week 40. The American Diabetes...

Innovative Food Holdings, Inc. Reports Financial Results For Third Quarter And First Nine Months Of 2020

Written by Customer Service on November 17, 2020. Posted in Earnings Releases And Operating Results.

Third Quarter E-commerce Revenue Increased 165% to a Third Quarter Record of $4.2 MillionThird Quarter Active E-commerce Customers Increased Over 150% Compared to the Prior Year PeriodEnhanced Specialty Food E-Commerce Platform Is Well Positioned for 2020 Online-Centric Holiday SeasonBONITA SPRINGS, Fla., Nov. 17, 2020 (GLOBE NEWSWIRE) — Innovative Food Holdings, Inc. (OTCQB: IVFH) (“IVFH” or the “Company”), a direct-to-chef and a direct-to-consumer platform that provides high-quality, unique specialty foods through e-commerce offerings and multichannel partnerships, today reported its financial results for the third quarter and first nine months of 2020.“The third quarter represents the culmination of two years of integrating, planning, and investing in our e-commerce platform. During the quarter, we launched our new igourmet.com...

Cosmos Holdings, Inc. Reports Record Third Quarter and Nine-Month Financial Results

Written by Customer Service on November 17, 2020. Posted in Earnings Releases And Operating Results.

Revenue Increases 48%, Gross profit increased 210% to $2.39 million andEarnings Rise over Same 2019 PeriodGenerics and Nutraceuticals Lead Expansion in EuropeRobotic Automations Enhance Margins and Reduce CostsCHICAGO, Nov. 17, 2020 (GLOBE NEWSWIRE) — Cosmos Holdings, Inc. (“the company”) (OTCQΒ: COSM), an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established EU distribution network, announced today record Third Quarter and Nine-Month results for the period ended September 30, 2020.Operating revenue rose 48 percent to $14.35 million from $9.68 million for the three months ended September 30, 2019; for the nine months, revenue increased 40 percent to $39.10 million from $27.88 million for the prior-year period. Gross...

Transom Capital-Backed SemiTorr Expands with Acquisition of M-I-C

Written by Customer Service on November 17, 2020. Posted in Mergers And Acquisitions.

LOS ANGELES, Nov. 17, 2020 (GLOBE NEWSWIRE) — Transom Capital Group-backed SemiTorr (www.semitorrinc.com) today announced that it has acquired M-I-C (www.m-i-cinc.com), which serves biotech, pharmaceutical and industrial customers throughout northern California. This is SemiTorr’s second add-on acquisition since being acquired by Transom Capital Group, a leading operations-focused middle market private equity firm, in December 2018.Ken Firtel, Managing Partner at Transom, said, “We’re pleased with SemiTorr’s growth, both organic and inorganic, and acquiring M-I-C continues the company’s strategy of expanding its customer base and diversifying its revenue streams through a focused add-on effort.”M-I-C is a distributor and manufacturers’ representation firm with over 45 years’ experience in the instrumentation and process control markets...

Day: November 17, 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals